BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 991 filers reported holding BAXTER INTL INC in Q3 2022. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $17,397,000 | -15.4% | 322,997 | +0.8% | 0.03% | -10.3% |
| Q2 2022 | $20,571,000 | -20.0% | 320,281 | -3.4% | 0.03% | -3.3% |
| Q1 2022 | $25,709,000 | +66.3% | 331,545 | +84.1% | 0.03% | +57.9% |
| Q4 2021 | $15,462,000 | +15.5% | 180,122 | +1.8% | 0.02% | 0.0% |
| Q3 2021 | $13,387,000 | -8.3% | 176,958 | -2.4% | 0.02% | -5.0% |
| Q2 2021 | $14,596,000 | -1.0% | 181,306 | +3.7% | 0.02% | -9.1% |
| Q1 2021 | $14,744,000 | -52.5% | 174,819 | -54.8% | 0.02% | -12.0% |
| Q4 2020 | $31,054,000 | -72.1% | 387,000 | -72.1% | 0.02% | -87.8% |
| Q3 2020 | $111,417,000 | -13.0% | 1,385,443 | -6.8% | 0.20% | -20.8% |
| Q2 2020 | $128,035,000 | +81.4% | 1,487,054 | +71.6% | 0.26% | +50.6% |
| Q1 2020 | $70,577,000 | -54.7% | 866,710 | -53.4% | 0.17% | -43.6% |
| Q4 2019 | $155,877,000 | -9.1% | 1,861,218 | -5.0% | 0.30% | -17.1% |
| Q3 2019 | $171,393,000 | +3.2% | 1,959,446 | -3.4% | 0.37% | +1.1% |
| Q2 2019 | $166,120,000 | -9.1% | 2,028,327 | -9.8% | 0.36% | -13.1% |
| Q1 2019 | $182,792,000 | +6.4% | 2,248,083 | -13.9% | 0.42% | -6.1% |
| Q4 2018 | $171,783,000 | +6.4% | 2,609,881 | +24.6% | 0.45% | +24.6% |
| Q3 2018 | $161,474,000 | +1.0% | 2,094,624 | -3.3% | 0.36% | -6.0% |
| Q2 2018 | $159,882,000 | +98.3% | 2,165,250 | +74.7% | 0.38% | +281.0% |
| Q1 2018 | $80,612,000 | +258.7% | 1,239,410 | +256.5% | 0.10% | +85.2% |
| Q4 2017 | $22,473,000 | +10.7% | 347,667 | +7.5% | 0.05% | +3.8% |
| Q3 2017 | $20,292,000 | +4.1% | 323,377 | +0.4% | 0.05% | +2.0% |
| Q2 2017 | $19,501,000 | +16.7% | 322,111 | 0.0% | 0.05% | +13.3% |
| Q1 2017 | $16,705,000 | +16.7% | 322,111 | -0.3% | 0.04% | +12.5% |
| Q4 2016 | $14,319,000 | -8.5% | 322,940 | -1.7% | 0.04% | -11.1% |
| Q3 2016 | $15,645,000 | +2.7% | 328,668 | -2.4% | 0.04% | +2.3% |
| Q2 2016 | $15,228,000 | +7.4% | 336,760 | -2.4% | 0.04% | 0.0% |
| Q1 2016 | $14,178,000 | -2.8% | 345,127 | -9.8% | 0.04% | +2.3% |
| Q4 2015 | $14,593,000 | +15.2% | 382,513 | -0.8% | 0.04% | +10.3% |
| Q3 2015 | $12,666,000 | -38.3% | 385,572 | +31.4% | 0.04% | -38.1% |
| Q2 2015 | $20,522,000 | -16.0% | 293,469 | -17.7% | 0.06% | -14.9% |
| Q1 2015 | $24,437,000 | -9.0% | 356,745 | -2.7% | 0.07% | -6.3% |
| Q4 2014 | $26,867,000 | +3.3% | 366,590 | +1.1% | 0.08% | +1.3% |
| Q3 2014 | $26,021,000 | -52.7% | 362,560 | -52.4% | 0.08% | -3.7% |
| Q2 2014 | $55,042,000 | +107.3% | 761,284 | +110.9% | 0.08% | +3.8% |
| Q1 2014 | $26,557,000 | +4.6% | 360,940 | -1.1% | 0.08% | +6.8% |
| Q4 2013 | $25,395,000 | +2.9% | 365,126 | -2.8% | 0.07% | -1.4% |
| Q3 2013 | $24,669,000 | -5.9% | 375,537 | -0.8% | 0.07% | -6.3% |
| Q2 2013 | $26,220,000 | – | 378,517 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |